Earnings History Data for Titan Pharmaceuticals, Inc. (TTNP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-08-2020 PM 8:45 AM ET
(Aug 14)
TTNP Titan Pharmaceuticals, Inc. 28.30 -1.50 -0.03 -0.38 Titan Pharmaceuticals EPS misses by $0.01, beats on revenue
[8/14/2020 8:48 AM]
0.2937 0.0 
0.3099 0.01 
0.14 - 0.74 3,753,402 3,658,910 486,193
15-05-2020 PM Before the open
(May 15)
TTNP Titan Pharmaceuticals, Inc. 29.72 -1.80 0.00 -0.34 Titan Pharmaceuticals beats on revenue
[5/15/2020 8:46 AM]
0.2750 -0.07 
0.2780 0.0 
0.14 - 1.96 30,752,200 18,675,472 459,370